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General	  Introduction	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  	   	  
	  	  	  	  	  	  	  Science	  has	  brought	  both	  great	  benefits	  and	  numerous	  hazards	  to	  humankind.	  It	  affects	  our	  social	  relations,	  comprising	  those	  nearby	  and	  the	  many	  we	  never	  get	  to	  see.	  Now,	  more	  than	  ever	  before,	  technology	  is	  influencing	  the	  way	  we	  live	  our	  daily	   lives.	   The	   shape	   and	   direction	   taken	   by	   science	   and	   the	   technologies	  developed	  in	  its	  wake	  are	  however	  something	  we	  can	  to	  a	  great	  extent	  control	  or	  at	   least	   attempt	   to	   steer	  with	  more	  or	   less	   success.	  A	  variety	  of	   incentives	   can	  align	  scientific	  progress	  with	  pre-­‐established	  targets.	  Yet,	   increasingly	  scientific	  agendas	   are	   being	   shaped	   by	   market	   incentives.	   In	   order	   to	   make	   scientific	  research	   lucrative	   intellectual	   property	   rights	   are	   granted	   to	   those	   who	   meet	  certain	   criteria	   that	   are	   defined	   by	   law.	   Exclusive	   rights	   have	   aroused	   fierce	  controversies	  for	  innovation	  in	  such	  vital	  areas	  as	  the	  life	  sciences.	  In	  a	  world	  of	  extreme	  inequalities	  this	  way	  of	  “incentivizing”	  innovation	  is	  bound	  to	  clash	  with	  deeply	  rooted	  notions	  of	  justice.	  	  Realizing	   that	   the	   direction	   science	   takes	   is	   something	  we	   can	   steer,	   creates	   a	  moral	  obligation	   to	  align	   the	  course	  of	  science	  more	  closely	  with	   the	  benefit	  of	  the	  larger	  global	  population.	  This	  demand	  however	  already	  reveals	  a	  normative	  position	  and	  as	  such,	  maintenance,	  deviation	  or	  intensification	  thereof	  becomes	  something	  that	  has	  to	  be	  justified.	  The	  liberties	  of	  some	  will	  clash	  with	  the	  rights	  of	  others.	  	  	  
Background	  of	  the	  research	  project	  	  Whilst	   states	   leaders	   from	   all	   around	   the	   world	   gathered	   in	   1994	   to	   sign	   the	  Trade-­‐related	   Aspects	   of	   Intellectual	   Property	   Rights	   Agreement,	   few	   realized	  the	   enormous	   consequences	   this	   will	   have	   on	   everyday	   life.	   The	   binding	  agreement	   made	   minimum	   intellectual	   property	   standards	   mandatory	   for	   all	  World	  Trade	  Organization	  member	  states.	  The	  agreement	  has	  strong	  power,	  as	  it	  is	   backed	   with	   an	   arbitration	   system	   to	   penalize	   non-­‐compliers	   with	   trade	  sanctions.	   The	   fact	   that	   the	   protection	   of	   intellectual	   property	   rights	   is	   now	  effectively	   a	   worldwide	   system	   calls	   traditional	   justifications	   of	   intellectual	  property	  protection	  into	  question	  and	  raises	  new	  ethical	   issues,	  especially	  with	  regard	  to	  global	  justice.	  	  Another	  prominent	  trend	  in	  recent	  decades	  has	  been	  the	  progressive	   enlargement	   of	   the	   subject	   matter	   that	   can	   be	   brought	   under	  intellectual	   property	   protection.	   The	   domain	   of	   patentable	   subject	   matter,	   for	  example,	   has	   been	   extended	   to	   include	   gene	   sequences,	   cultured	   cell	   lines	   and	  
tissues,	   live	   organisms,	   computer	   programs	   and	   also	   (in	   the	   United	   States	   at	  least)	  new	  business	  methods.	  As	   intellectual	  property	   rights	   increasingly	  cover	  the	   strategic	   information-­‐intensive	   assets	   of	   the	   new	   knowledge-­‐based	  bioeconomy	   (like	   seeds,	   food,	   medicines	   and	   diagnostic	   tools),	   they	   become	  deeply	   implicated	   in	   the	   essential	   requirements	   for	   the	   sustenance	   and	  flourishing	  of	  human	  life.	  	  The	  discussion	  on	  intellectual	  property	  in	  the	  life	  sciences	  and	  global	  justice	  has	  primarily	   concentrated	   on	   two	   issues:	   accessibility	   and	   availability	   of	   the	  resulting	   objects	   of	   innovative	   efforts.1	  Accessibility	  means	   in	   this	   context	   that	  innovations	  should	  be	  accessible	  to	  those	  who	  urgently	  need	  them.	  Availability	  is	  a	   term	   used	   to	   discuss	   the	   problem	   of	   a	   highly	   skewed	   allocation	   of	   research	  efforts,	   as	   exemplified	   in	   the	   well-­‐known	   “10-­‐90	   gap”	   in	   pharmaceutical	  research,	   where	   no	   more	   than	   10	   per	   cent	   of	   the	   entire	   research	   effort	   is	  reportedly	   devoted	   to	   finding	   cures	   for	   diseases	   that	   afflict	   90	   per	   cent	   of	   the	  world’s	  population.	  Similar	  gaps	  exist	  in	  other	  fields	  of	  research.	  While	  it	  is	  acknowledged	  that	  innovators	  should	  be	  fairly	  remunerated,	  allowing	  access	   to	   only	   those	   who	   pay	   the	   established	   prices	   is	   controversial	   for	   such	  objects	   as	   vital	   medicines.	   After	   the	   successful	   eradication	   of	   such	   dreadful	  diseases	  as	  smallpox	  the	  scientific	  community	  finds	  itself	  under	  huge	  pressure	  to	  repeat	  earlier	  achievements	  by	  making	  medicines	  available	  for	  other	  diseases	  as	  well.	   The	   suffering	   of	   millions	   of	   people	   is	   not	   perceived	   anymore	   as	   an	  inevitable	   burden	   on	   daily	   life	   that	   we	   are	   not	   capable	   to	   curb.	   Similarly	  technological	  solutions	  are	  sought	  for	  countless	  other	  social	  problems,	  be	  it	  food	  security,	  pollution	  control	  or	  climate	  change	  mitigation	  and	  adaptation.2	  	  Although	  those	  first	  two	  allocation	  problems	  –	  accessibility	  and	  availability	  –	  are	  far	  from	  solved,	  two	  further	  issues	  that	  are	  somewhat	  neglected	  in	  the	  discussion	  also	   deserve	   attention:	   the	   highly	   unequal	   distribution	   of	   intellectual	   property	  rights	   themselves	   and	   the	  manner	   those	   exclusive	   rights	   affect	   the	   practice	   of	  science.	  The	   highly	   unequal	   distribution	   of	   intellectual	   property	   rights	   between	   the	  Global	   North	   and	   the	   Global	   South	   can	   be	   identified	   as	   the	   third	   distributive	  justice	   problem	   raised	   by	   intellectual	   property	   regimes. 3 	  Such	   extreme	  inequalities	   have	   a	   negative	   effect	   on	   multiple	   dimensions.	   First,	   the	   divide	  between	  technology	  receivers	  and	  technology	  producers	  widens,	  thus	  creating	  a	  situation	  where	  financial	  flows	  occur	  mostly	  one	  way:	  from	  the	  Global	  South	  to	  the	  Global	  North.4	  Second,	  people	  who	  regularly	  use	   the	  system	  are	  placed	   in	  a	  position	  of	  advantage	  due	  to	  their	  greater	  legal	  expertise	  on	  what	  is	  patentable	  and	   what	   is	   not.	   A	   number	   of	   institutions	   have	   used	   their	   legal	   expertise	   to	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  cf.	  Pogge	  (2005)	  2	  cf.	  Acharya	  et	  al.	  (2004)	  3	  cf.	  DeCamp	  (2007)	  4	  cf.	  De	  Schutter	  (2011)	  
acquire	  patents	  on	   foreign	   inventions	   that	  were	  not	  or	   insufficiently	  protected.	  This	   is	   a	   phenomenon	   that	   in	   the	   life	   sciences	   is	   widely	   known	   as	   biopiracy.	  Especially	   indigenous	   innovators	   are	   vulnerable	   to	   such	   abusive	   practices	   and	  thereby	  lose	  an	  opportunity	  to	  be	  recognized	  and	  rewarded	  for	  their	  creativity.	  Third,	   managing	   a	   vast	   patent	   portfolio	   gives	   companies	   some	   control	   over	  follow-­‐up	   innovations.	   Newcomers	   are	   often	   in	   a	   position	   of	   disadvantage,	   as	  they	   may	   have	   to	   spend	   considerable	   funds	   in	   acquiring	   licenses.	   This	   is	  generally	   a	   problem	   for	   companies	   and	   research	   institutions	   with	   smaller	  budgets.5	  Patents	  may	  even	  discourage	  or	  stifle	  follow-­‐on	  innovation,	  contrary	  to	  their	  official	  rationale.	  	  Intellectual	  property	  has	  had	  also	  a	  strong	  effect	  on	  the	  practice	  of	  science.	  First,	  it	   has	   profoundly	   strengthened	   the	   belief	   that	   science	   can	   and	   should	   be	   self-­‐financeable.	  This	  has	  a	  negative	  effect	  on	  all	  types	  of	  scientific	  work	  that	  cannot	  be	   protected	   by	   intellectual	   property,	  most	   prominently:	   rediscovery,	  much	   of	  indigenous	   innovation,	   fundamental	   research	   and	   incremental	   innovation.	  Second,	  favouring	  one	  type	  of	  scientific	  work	  over	  other	  forms	  implies	  that	  one	  has	  a	  greater	  societal	  value	  than	  the	  other.	  In	  many	  cases	  this	  has	  nothing	  to	  do	  with	   social	   utility	   –	   many	   individuals	   and	   communities	   who	   provide	   vital	  services	  to	  society	  are	  widely	  misrecognized	  for	  their	  work.	  Additionally,	  one	  has	  to	   keep	   in	   mind	   that	   most	   people	   do	   not	   have	   the	   resources	   to	   apply	   for	  intellectual	   property	   protection.	   Third,	   intellectual	   property	   demands	   that	  innovation	   offers	   products	   that	   are	   homogeneous,	   something	   that	   disfavours	  indigenous	   innovation	   and	   is	   a	   disincentive	   for	   the	   maintenance	   of	  agrobiodiversity.6	  Innovators	   who	   primarily	   produce	   a	   heterogeneous	   output	  are	  less	  attractive	  research	  partners	  to	  collaborate	  with.	  	  	  
Research	  questions	  	  The	  vast	  problems	  and	  opportunities	  raised	  by	  the	  intellectual	  property	  regimes	  in	   the	   life	   sciences	   give	   rise	   to	   a	  number	  of	   questions.	  However,	   a	  major	   issue	  that	   is	   inadequately	   addressed	   in	   the	   discussion	   is	   the	   necessity	   to	   make	  research	   and	   technology	   development	   a	   more	   inclusive	   endeavour.	   Since	   this	  matter	  is	  worthy	  of	  more	  scholarly	  attention	  I	  have	  decided	  to	  make	  it	  central	  by	  building	   the	   following	   six	   main	   research	   questions	   around	   this	   topic.	   First,	   I	  deemed	  it	  necessary	  to	  offer	  a	  brief	  exposition	  of	  the	  main	  ethical	  arguments	  that	  justify	  access	  to	  innovation	  and	  demand	  that	  technological	  solutions	  that	  address	  the	   problems	   of	   the	   poor	   become	   available.	   An	   over-­‐emphasis	   on	   access	   and	  availability	   made	   me	   however	   ponder	   a	   world	   where	   scientific	   participation	  possibilities	   are	   deliberatively	   left	   aside.	   This	   led	   to	   the	   formulation	   of	   the	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  cf.	  Eppinger	  and	  Vladova	  (2013)	  6	  On	  the	  problem	  of	  industrial	  agricultural	  innovation	  and	  genetic	  erosion,	  see	  De	  Schutter	  (2011)	  
second	  question.	  In	  the	  third	  question	  I	  articulate	  the	  main	  problems	  brought	  up	  by	   highly	   unequal	   formal	   research	   capacities	   distributions	   between	   the	   Global	  North	   and	   the	   Global	   South	   with	   a	   corresponding	   pattern	   in	   the	   allocation	   of	  intellectual	   property	   rights.	   To	   counter	   arguments	   coming	   from	   neoliberal	  quarters	   I	   found	   it	   necessary	   to	   criticize	   conventional	   methods	   to	   judge	   the	  quality	   and	   quantity	   of	   research	   outputs.	   Hence	   the	   fourth	   question.	   The	   fifth	  point	   I	   want	   to	   bring	   into	   discussion	   is	   a	   specific	   problem	   raised	   by	   the	   way	  intellectual	  property	  affects	  scientific	  practice:	  the	  fate	  of	  traditional	  knowledge.	  Much	  of	  traditional	  knowledge	  becomes	  lost	  by	  the	  lack	  of	  incentives	  to	  continue	  its	   development.	   The	   last	   question	   raised	   wraps	   up	   the	   thesis	   by	   evaluating	  amendment	  proposals.	  Verbatim,	  the	  guiding	  research	  questions	  are:	  	  	   1. What	  are	  the	  main	  ethical	  theories	  that	  justify	  fairer	  access	  to	  innovation?	  This	  question	  addresses	   the	  different	   theories	  used	  to	   justify	  access	  and	  availability	  of	  innovations	  for	  those	  in	  need.	  2. Should	   one	   consider	   scientific	   participation	   possibilities	   as	   a	   luxury	   to	   be	  
left	   aside	   until	   subsistence	   rights	   for	   the	   great	   majority	   of	   people	   are	  
secured?	   Access	   to	   innovation	   and	   sufficient	   research	   attention	  (availability	  of	  solutions)	  can	  be	  justified	  under	  subsistence	  rights.	  Efforts	  to	  make	  science	  more	  inclusive	  are	  often	  left	  aside	  with	  the	  argument	  that	  subsistence	  rights	  take	  precedence.	  	  3. Should	  extreme	  inequalities	  in	  research	  capacities	  between	  the	  Global	  South	  
and	   the	   Global	   North	   be	   fought	   even	   when	   the	   objects	   of	   innovation	   are	  
made	  accessible	  worldwide?	   Since	   inequalities	   in	   research	   capacities	  will	  unavoidably	   affect	   the	   allocation	   of	   exclusive	   rights,	   this	   question	  addresses	   the	   third	   distributive	   justice	   problem:	   the	   negative	   impact	   of	  highly	  unequal	  distribution	  of	  intellectual	  property	  rights.	  	  4. What	  are	  the	  benefits	  to	  be	  expected	  from	  research	  and	  innovation	  and	  how	  
do	   we	   judge	   that	   the	   international	   system	   of	   science	   and	   technology	   is	  
working	   properly?	   Is	   the	   number	   of	   patents	   an	   appropriate	   metric	   for	  measuring	   innovative	   output?	   Different	   inventions	   that	   have	   the	   same	  function	  often	  vary	  strongly	  in	  terms	  of	  positive	  and	  negative	  side	  effects.	  How	   do	   we	   make	   sure	   that	   innovations	   with	   the	   most	   valuable	  externalities	  are	  made	  available	  to	  the	  poor?	  5. How	   can	   we	   secure	   the	   moral	   and	   material	   interests	   of	   indigenous	  
innovators	   using	   the	   current	   intellectual	   property	   regimes?	   Much	   of	  indigenous	   creative	   efforts	   are	   not	   patentable.	   Incentivizing	   indigenous	  innovation	   as	   a	   parallel	   system	   of	   innovation	   would	   make	   the	   current	  science	   and	   innovation	   practice	   (the	   earlier	   mentioned	   fourth	   issue)	  much	   more	   inclusive	   by	   facilitating	   the	   participation	   of	   those	   who	  currently	  are	  underrepresented.	  	  
6. Is	   there,	   among	   the	   various	   proposals	   that	   have	   been	  brought	   forward	   to	  
enhance	   the	   global	   justice	   of	   the	   international	   intellectual	   property	   and	  
research	  system,	  any	  amendment	  proposal	  that	  should	  be	  clearly	  favoured?	  An	   evaluation	   is	   needed	   to	   identify	   which	   amendment	   proposal	   best	  addresses	  the	  issues	  of	  access	  to	  and	  availability	  of	  objects	  of	  innovation,	  reduces	  the	  negative	  effects	  of	  highly	  unequal	  distribution	  of	   intellectual	  property	  rights	  and	  is	  conducive	  to	  good	  science	  and	  innovation	  practices.	  	  	  Having	   introduced	   the	   questions,	   I	   will	   move	   on	   by	   explaining	   the	   research	  methodology	  used	  in	  this	  thesis.	  	  	  
Research	  methodology	  	  Insights	  to	  answer	  the	  research	  questions	  were	  gained	  by	  an	  extensive	  study	  of	  literature.	   In	   the	  selection	  of	  material	   I	  made	  sure	  that	  works	   from	  all	  relevant	  disciplines	   were	   included.	   Most	   of	   the	   analysed	   literature	   comes	   from	  philosophy,	   political	   science,	   law,	   economics	   and	   anthropology.	   To	   a	   lesser	  extent	   literature	   from	   disciplines	   such	   as	   life	   sciences,	   development	   studies,	  business	  and	  innovation	  management,	  history	  of	  science	  and	  technology,	  public	  health	  and	  engineering	  was	  also	  examined.	  	  While	  this	  is	  a	  philosophical	  thesis,	  I	  also	  used	  methods	  that	  are	  not	  commonly	  employed	   in	   the	   discipline.	   The	   thesis	   gained	   in	   strength	   by	   including	   the	  methods	  of	  empirical	  philosophy,	  a	  practice	  that	  has	  become	  fairly	  widespread	  in	  the	   Netherlands:	   conversations	   with	   stakeholders	   and	   critical	   analysis	   of	  empirical	  data.	  One	  of	  the	  highlights	  here	  was	  the	  organization	  of	  a	  networking	  conference	   in	   Brussels	   September	   2011.7	  Michiel	   Korthals	   and	   I	   organized	   the	  conference	   with	   substantial	   support	   from	   the	   Centre	   for	   Society	   and	   the	   Life	  Sciences.	   We	   brought	   together	   specialists	   from	   a	   diverse	   range	   of	   disciplines	  working	   in	   academia,	   public	   sector,	   industry	   and	   NGOs.	   This	   exceptional	  environment	   fostered	   a	   high	   level	   of	   discussions	   dealing	   with	   global	   justice	  concerns	   raised	  by	   the	   intellectual	  property	   regimes	   in	   the	   life	   sciences.	  There	  was	   ample	   room	   to	   debate	   ideas	   and	   concerns	   and	   this	   opportunity	  was	  well	  used.	  I	  gained	  immensely	  from	  discussions	  with	  the	  participants,	  some	  of	  which	  commented	   on	   later	   developed	   papers.	   Thomas	   Pogge’s	   work	   also	   was	  exemplary	  in	  showing	  how	  to	  harness	  a	  critical	  analysis	  of	  empirical	  data	  for	  the	  purpose	  of	  ethical	  assessment.	  	  My	   involvement	   in	   several	   research	   environments	   gave	   substantial	   material	  input	   to	   the	   subject	   of	   investigation.	   Based	   at	   Wageningen	   University,	   I	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  Korthals	  and	  Timmermann	  (2012)	  [here	  reproduced	  as	  Chapter	  4]	  
participated	  in	  the	  interdisciplinary	  “Commons	  Seminar”	  and	  in	  a	  series	  of	  guest	  lectures,	   meetings	   and	   seminars.	   The	   university’s	   focus	   on	   agriculture	   and	  international	  development	  gave	  me	  countless	  opportunities	  to	  gain	  new	  insights	  and	   rectify	   false	  assumptions.	  Being	  also	  a	  member	  of	   interuniversity	   research	  group,	  the	  Centre	  for	  Society	  and	  the	  Life	  Sciences	  allowed	  me	  to	  discuss	  topics	  with	  people	  working	  primarily	  on	  health-­‐related	   issues.	  A	   two-­‐month	   research	  stay	   at	   the	   Brocher	   Foundation	   gave	   me	   the	   opportunity	   to	   strengthen	   the	  knowledge	   gained	   through	   extensive	   interdisciplinary	   discussions	   with	  researchers	  from	  different	  parts	  of	  the	  world.	  	  
Overview	  of	  the	  thesis	  	  After	  this	  general	  introduction,	  the	  second	  chapter	  commences	  by	  setting	  out	  the	  major	   arguments	   for	   making	   objects	   of	   innovation	   accessible	   and	   directing	  research	  attention	  to	  make	  technological	  solutions	  for	  the	  global	  poor	  available.	  The	  research	  question	  here	  answered	  is:	  What	  are	  the	  main	  ethical	  theories	  that	  
justify	   fairer	   access	   to	   innovation?	   After	   that	   I	   state	   what	   makes	   life	   sciences	  different	  to	  other	  fields	  of	  knowledge.	  	  The	  third	  chapter	  is	  the	  main	  theoretical	  chapter.	  A	  philosophical	  interpretation	  of	  a	  segment	  of	  article	  27	  of	  the	  Universal	  Declaration	  of	  Human	  Rights	  serves	  as	  the	  centrepiece	  of	  this	  chapter	  that	  introduces	  the	  concept	  of	  global	  justice	  used	  throughout	   the	   thesis.	   The	   aim	   of	   this	   interpretative	   analysis	   is	   to	   give	   an	  extensive	  answer	  to	  the	  second	  research	  question:	  Should	  one	  consider	  scientific	  
participation	  possibilities	  as	  a	  luxury	  to	  be	  left	  aside	  until	  subsistence	  rights	  for	  the	  
great	  majority	  of	  people	  are	  secured?	  Here	  the	  consequences	  of	  prioritizing	  any	  of	  the	   two	   elements	   of	   this	   article,	   i.e.	   the	   possibility	   to	   share	   in	   scientific	  advancement	   or	   to	   benefit	   from	   access	   to	   and	   availability	   of	   objects	   of	  innovation,	  are	  analysed	  in	  regard	  to	  global	  justice.	  This	  chapter	  also	  addresses	  partly	   the	   third	   research	   question:	   Should	   extreme	   inequalities	   in	   research	  
capacities	  between	  the	  Global	  South	  and	  the	  Global	  North	  be	  fought	  even	  when	  the	  
objects	   of	   innovation	   are	   made	   accessible	   worldwide?	   Huge	   inequalities	   in	  research	   capacities	   are	   condemned	   with	   the	   introduction	   of	   the	   concept	   of	  dependency:	  the	  situation	  where	  one	  party	  is	  always	  the	  one	  “saving”	  the	  other	  through	  technological	  aid.	  	  In	   the	   fourth	   chapter	   we	   move	   from	   discussing	   the	   theoretical	   framework	   to	  offering	   a	   report	   representing	   the	   current	   state	   of	   the	   debate.	   This	   chapter	  reports	  the	  outcomes	  of	  the	  “Network	  Conference	  on	  Ethical	  and	  Social	  Aspects	  of	   Intellectual	   Property	   Rights	   –	   Agrifood	   and	   Health”	   held	   in	   Brussels,	  September	   2011	   and	   concludes	   by	   offering	   a	   philosophical	   reflection	   on	   the	  debate.	  This	  chapter	  turns	  around	  two	  questions:	  what	  are	  the	  main	  problems	  of	  
the	   current	   intellectual	   property	   regimes?	   And,	   what	   can	   society	   do	   to	   mend	  them?	  It	  also	  provides	  some	  accounts	  on	  the	  negative	  effects	  raised	  by	  the	  high	  concentration	   of	   intellectual	   property	   rights	   among	   a	   few	  major	  multinational	  companies.	  	  After	   the	   theoretical	   framework	  and	   the	   current	   state	  of	   the	  debate	  have	  been	  presented,	  we	  continue	  with	  the	  analysis	  of	  three	  proposals	  that	  seek	  to	  alleviate	  the	  negative	  effects	  of	  current	  intellectual	  property	  regimes.	  Those	  proposals	  are	  the	   Access	   to	   Knowledge	   movement,	   the	   Health	   Impact	   Fund	   and	   open	  innovation	   models.	   In	   order	   to	   offer	   a	   critical	   perspective,	   each	   proposal	   is	  discussed	   in	   relation	   to	   a	   specific	   problem	   field:	   access	   to	   medicines,	   the	  promotion	   of	   climate-­‐friendly	   technologies	   and	   the	   issue	   of	   traditional	  knowledge.	  	  
Chapter	  5.	   The	   access	   to	   knowledge	  movement	   is	   discussed	   by	   using	   the	  most	  prominent	  conflicting	  issue	  with	  the	  patent	  system:	  the	  need	  to	  make	  medicines	  accessible	   for	   the	   poor	   and	   stimulate	   research	   on	   neglected	   diseases.	   The	  chapter	   offers	   a	   historical	   overview	   of	   the	   debate	   since	   the	   early	   1980s.	   The	  landmarks	   of	   the	   debate	   are	   narrated	   by	   addressing	   the	   question:	   What	  initiatives	  have	  been	  taken	  in	  making	  medicines	  available	  and	  accessible	  during	  the	  last	  thirty	  years?	  The	  chapter	  also	  evaluates	  the	  strengths	  and	  weaknesses	  of	  these	  various	  initiatives.	  	  
Chapter	  6.	   Focussing	  on	   the	   latest	  version	  of	   the	  Health	   Impact	  Fund	  proposal,	  we	  criticise	  the	  hard	  prioritarian	  position	  defended	  by	  Thomas	  Pogge	  and	  see	  it	  as	  a	  major	  hurdle	  for	  ensuring	  scientific	  participation	  possibilities	  for	  the	  global	  poor.	   As	   climate-­‐friendly	   technologies	   do	   not	   necessarily	   have	   to	   be	   rooted	   in	  industrial	  innovation	  to	  meet	  their	  target,	  excluding	  the	  stimulation	  of	  grassroots	  innovation	  becomes	  even	  harder	  to	  justify.	  Grassroots	  innovators	  are	  developing	  many	  methods	  that	  can	  be	  useful	  to	  reduce	  the	  carbon	  footprint	  in	  agriculture	  –	  stimulating	  them	  would	  not	  only	  do	  good	  to	  the	  planet	  but	  also	  support	  a	  more	  inclusive	   innovation	   system.	   This	   chapter	   responds	   to	   the	   third	   and	   fourth	  research	  question:	  Should	  extreme	  inequalities	  in	  research	  capacities	  between	  the	  
Global	  South	  and	  the	  Global	  North	  be	  fought	  even	  when	  the	  objects	  of	   innovation	  
are	  made	  accessible	  worldwide?	   And:	  What	  are	   the	  benefits	   to	  be	   expected	   from	  
research	   and	   innovation	   and	   how	   do	   we	   judge	   that	   the	   international	   system	   of	  
science	   and	   technology	   is	   working	   properly?	   A	   special	   emphasis	   on	   the	   latter	  question	   is	  given	  by	  criticizing	   the	  use	  of	  a	  unique	  metric	   (quality-­‐adjusted	   life	  years)	  to	  measure	  the	  positive	  impact	  of	  a	  whole	  group	  of	  innovations.	  Widening	  the	  circle	  of	   innovators	   is	  suggested	  as	  a	  strategy	   to	  make	  sure	   that	   inventions	  are	   brought	   up	   who	   have	   valuable	   externalities.	   I	   also	   critically	   discuss	   the	  widely	  used	  metric	  of	  the	  number	  of	  patents	  as	  a	  purportedly	  reliable	  measure	  of	  innovative	  output.	  
	  
Chapter	   7.	   Open	   innovation	   is	   not	   the	   ideal	   solution	   to	   secure	   the	   material	  interests	   of	   traditional	   knowledge	   holders.	   Using	   a	   dynamic	   concept	   of	  traditional	  knowledge,	  that	  encompasses	  all	   the	   innovation	  done	  by	  small-­‐scale	  farmers	   and	   indigenous	   communities,	   I	   argue	   that	   worse	   than	   seeing	   one’s	  profits	   opportunities	   forgo	   is	   to	   see	  one’s	   innovative	   efforts	   go	   to	  waste.	  Open	  innovation	  models	  allow	  users	  to	  secure	  their	  moral	   interests	  as	  recognized	  by	  law,	  i.e.	  the	  right	  to	  attribution	  of	  authorship	  and	  the	  possibility	  of	  having	  control	  over	   the	   integrity	   of	   one’s	   work.	   In	   addition	   to	   that,	   I	   argue	   that	   another	  fundamental	  moral	  interest	  that	  is	  not	  protected	  by	  law	  can	  be	  secured	  with	  the	  use	  of	  open	  innovation	  models:	  that	  one’s	  invention	  is	  fairly	  evaluated	  in	  terms	  of	  its	  capacity	  to	  promote	  societal	  welfare.	  Those	  are	  the	  central	  arguments	  that	  provide	  an	  answer	   to	   the	   fifth	   research	  question:	  How	  can	  we	  secure	  the	  moral	  
and	   material	   interests	   of	   indigenous	   innovators	   using	   the	   current	   intellectual	  
property	  regimes?	  	  The	   final	  part	  of	   the	   thesis	   re-­‐examines	   the	   insights	  gained	  earlier	  and	   tries	   to	  see	   how	   far	   apart	   they	   are	   from	  positions	   defended	  by	   groups	   involved	   in	   the	  intellectual	  property	  and	  global	  justice	  advocacy.	  	  	  The	  aim	  of	  the	  eighth	  chapter	  is	  to	  wrap	  up	  the	  thesis	  by	  analysing	  the	  question	  Is	  
there,	  among	  the	  various	  proposals	  that	  have	  been	  brought	  forward	  to	  enhance	  the	  
global	   justice	   of	   the	   international	   intellectual	   property	   and	   research	   system,	   any	  
amendment	  proposal	  that	  should	  be	  clearly	  favoured?	  Here	  an	  assessment	  of	   six	  major	   proposals	   to	   alleviate	   the	   negative	   effects	   of	   the	   current	   intellectual	  property	   regimes	   is	   made.	   Those	   include	   the	   three	   analysed	   proposals:	   the	  Health	   Impact	   Fund,	   the	  Access	   to	  Knowledge	  movement	   and	   open	   innovation	  models.	   Three	   additional	   proposals	   were	   added	   to	   make	   this	   study	   more	  extensive:	   prize	   systems	   (including	   advanced	   market	   commitments),	   South-­‐South	  partnerships	  and	  compulsory	  licenses.	  	  	  Finally,	  Chapter	  9	  will	  offer	  some	  concluding	  remarks.	  Here	  I	  will	  briefly	  discuss	  the	  answers	  to	  the	  research	  questions	  stated	  at	  the	  beginning	  of	  the	  thesis.	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  The	   human	   right	   to	   participate	   in	   the	   advancement	   of	   science	   is	   frequently	  overlooked	  in	  the	  intellectual	  property	  and	  global	  justice	  discourse.	  This	  thesis	  is	  a	  contribution	   to	  efforts	   that	  aim	  at	   filling	   this	  gap	   in	   the	  overall	  discussion	  on	  proper	  incentives	  for	  the	  life	  sciences.	  	  	  Three	   distributive	   justice	   problems	   are	   raised	   by	   our	   intellectual	   property	  regimes	   (cf.	   DeCamp	   2007).	   First,	   high	   prices	   make	   objects	   of	   innovation	  inaccessible,	   even	   in	   those	   cases	   where	   the	   object	   is	   urgently	   needed	   (i.e.	   the	  accessibility	  problem).	  Second,	  research	  efforts	  concentrate	  primarily	  in	  fulfilling	  the	  wishes	  of	  richer	  customers.	  This	  has	  lead	  to	  the	  10/90	  gap	  in	  pharmaceutical	  research,	   the	   situation	   where	   90%	   of	   the	   resources	   are	   destined	   to	   solve	   the	  problems	  and	  desires	  of	  10%	  of	  the	  world	  population.	  The	  consequence	  thereof	  is	  that	  research	  and	  development	  addressed	  to	  make	  available	  solutions	  for	  the	  needy	   is	   insufficient	   (i.e.	   the	   availability	   problem).	   Third,	   the	   distribution	   of	  intellectual	  property	  rights	  themselves	  is	  highly	  imbalanced	  between	  the	  Global	  South	  and	  the	  Global	  North.	  This	  brings	  with	  itself	  a	  huge	  transfer	  of	  resources	  from	   the	   developing	   to	   the	   developed	  world	   and	   it	   gives	   intellectual	   property	  owners	   a	   considerable	   amount	   of	   control	   over	   follow-­‐up	   innovation.	   The	   first	  two	  problems	  have	  attracted	  a	  considerable	  amount	  of	  scholarly	  work	  and	  policy	  studies.	   Therefore	   I	   have	   concentrated	  my	   attention	   to	   the	   third	   problem	   and	  identified	   a	   fourth	   issue	   that	   is	   in	   need	   of	  more	   careful	   analysis:	   the	   influence	  intellectual	   property	   has	   on	   scientific	   conduct	   and	   scientific	   participation	  possibilities.	  	  	  The	  thesis	  starts	  with	  two	  introductory	  chapters,	  the	  second	  briefly	  exposes	  the	  different	   arguments	   that	   justify	   pro-­‐poor	   innovation:	   utilitarianism,	  compensatory	  duties,	  the	  basic	  rights	  doctrine,	  the	  human	  rights	  and	  capabilities	  discourse,	   recognition	   theories,	   cooperative	   justice	   arguments,	   the	   need	   to	  (re)claim	  the	  commons	  and	  uphold	  shared	  scientific	  values.	  In	  the	  same	  manner	  arguments	   for	  restricting	  access	  are	  discussed	  before	   listing	  some	  of	   the	   issues	  that	  make	  life	  sciences	  special	  in	  relation	  to	  intellectual	  property.	  	  	  The	  third	  chapter	  defends	  the	  ethical	  standpoint	  sustained	  throughout	  the	  thesis.	  Using	   the	   capabilities	   approach	   it	   is	   argued	   that	  being	  able	   to	  actively	   care	   for	  others	  should	  not	  only	  apply	  to	  efforts	  made	  through	  physical	  work,	  but	  also	  that	  one	  should	  be	  in	  a	  position	  to	  help	  others	  by	  using	  one’s	  intellectual	  capacities.	  With	   the	   help	   of	   recognition	   theories	   the	   relation	   of	   technological	   dependency	  
between	   the	   Global	   South	   and	   the	   Global	   North	   is	   criticized.	   People	   should	   be	  able	   to	  mutually	   influence	  each	  other	  and	  be	  able	   to	  assist	  one	  another.	  Those	  two	   main	   ideas	   are	   used	   to	   justify	   a	   right	   to	   partake	   in	   the	   advancement	   of	  science	  as	  a	  peer.	  	  	  After	   having	   set	   out	   the	   moral	   framework	   used	   in	   the	   thesis,	   the	   state	   of	   the	  debate	   is	   presented	   through	   a	   report	   on	   a	   stakeholder	   conference	   held	   in	  Brussels	   in	   September	   2011	   on	   the	   ethical	   and	   social	   aspects	   of	   intellectual	  property	  in	  the	  life	  sciences.	  This	  report	  constitutes	  the	  fourth	  chapter.	  	  	  	  A	   series	   of	   proposals	   and	   alternatives	   have	   been	   put	   forward	   to	   alleviate	   the	  negative	  effects	  of	  intellectual	  property	  regimes.	  In	  this	  thesis	  three	  of	  these	  are	  analysed	   in	   terms	  of	   their	   strengths	  and	  weaknesses:	   the	  Access	   to	  Knowledge	  movement,	  the	  Health	  Impact	  Fund	  and	  open	  innovation	  models.	  In	  order	  to	  gain	  a	   clearer	   insight,	   these	   alternatives	   are	   evaluated	   by	   contrasting	   them	   to	   a	  particular	   problem.	   First,	   the	   Access	   to	   Knowledge	   movement	   is	   analysed	   in	  terms	  of	  its	  capacity	  to	  improve	  global	  health.	  Then,	  it	  is	  examined	  how	  the	  idea	  behind	   the	  Health	   Impact	   Fund	   could	   be	   used	   to	   promote	   the	   development	   of	  climate-­‐friendly	   technologies.	   Lastly,	   open	   innovation	   models	   are	   tested	   in	  regard	   to	   their	   potential	   to	   conserve	   and	   incentivize	   innovation	   in	   indigenous	  communities.	  	  	  Chapter	  five	  analyses	  the	  access	  to	  medicines	  movement	  during	  the	  last	  twenty	  years,	   describing	  how	   the	  movement	   changed	   from	  being	  one	   about	   corporate	  social	   responsibility	   towards	  being	  a	  matter	  of	   justice.	  The	  situation	  where	   the	  Global	   North	   is	   developing	   nearly	   all	   the	   essential	   pharmaceuticals	   has	   some	  drawbacks	  for	  the	  poor.	  Medicines	  are	  mainly	  developed	  to	  be	  effective	  against	  pathogens	   prevalent	   in	   the	   Global	   North	   and	   little	   attention	   is	   paid	   that	  medicines	   are	   still	   effective	   in	   resource	   poor	   settings.	   In	   addition,	   market	  incentives	   make	   the	   development	   of	   “me-­‐too	   drugs”	   lucrative	   and	   generally	  encourage	   researchers	   to	   enclose	   their	  work	  which	  often	   leads	   to	  unnecessary	  repetition	   of	   research	   efforts.	   The	   chapter	   ends	   with	   a	   spark	   of	   optimism	   by	  presenting	  some	  new	  initiatives	  that	  work	  with	  “open	  laboratories”,	  thus	  making	  science	  a	  more	  inclusive	  endeavour.	  	  	  Chapter	  six	  critically	  examines	  the	  potentials	  and	  shortfalls	  of	  the	  Health	  Impact	  Fund.	  The	  criticism	  concentrates	  around	  the	  failure	  to	  tackle	  the	  strong	  research	  divide	  between	  the	  Global	  North	  and	  the	  Global	  South.	  The	  chapter	   is	  sceptical	  about	   the	   opportunities	   to	   overcome	   this	   divide	   even	   after	   considering	  modifications	   to	   the	  original	  proposal.	  The	  application	  of	  a	  modified	  version	  of	  the	   Health	   Impact	   Fund	   for	   propagating	   climate-­‐friendly	   technologies	   is	   even	  more	  problematic	  than	  its	  original	  use	  in	  the	  context	  of	  medicines.	  Technologies	  that	  help	  mitigate	  climate	  change	  may	  have	  considerable	  positive	  side-­‐effects	  for	  
its	  users.	  Incentivizing	  the	  fuel	  efficiency	  for	  luxury	  boats	  or	  the	  improvement	  of	  stoves	   that	  also	  reduce	   the	  exposure	   to	   fumes	   in	  crowded	  households	  are	  very	  different	   things	  –	  having	  chosen	  one	  strategy	   instead	  of	   the	  other	   is	  something	  that	  one	  has	  to	  be	  able	  to	  morally	  defend.	  The	  example	  of	  biochar	  is	  discussed	  in	  the	  chapter.	  In	  order	  to	  be	  politically	  feasible,	  the	  drafters	  of	  the	  Health	  Impact	  Fund	  make	  too	  broad	  concessions	  to	  major	  players	  of	  the	  political	  arena.	  	  The	   next	   chapter	   discusses	   the	   third	  movement.	   Open	   innovation	  models	  may	  not	  be	  the	  best	  alternative	  to	  secure	  the	  material	  needs	  of	  indigenous	  innovators.	  However,	   they	   have	   great	   potential	   in	   protecting	   the	   moral	   interests	   of	   these	  creative	  minds.	  Here	  the	  idea	  of	  moral	  interest	  is	  understood	  in	  a	  broader	  sense	  than	   the	   one	   specified	   by	   law.	   Not	   only	   do	   innovators	   have	   an	   interest	   in	  attribution	  of	   authorship	  and	   retaining	  a	   control	  of	   the	   integrity	  of	   their	  work,	  but	   also	   in	   a	   fair	   evaluation	   of	   their	   invention.	   Being	   unjustly	   forgotten	  contradicts	   this	   interest.	   Platforms	   that	   make	   indigenous	   innovation	   visible	   –	  especially	  among	  people	  living	  in	  similar	  conditions	  in	  other	  parts	  of	  the	  world	  –	  have	  a	  great	  potential	  in	  addressing	  this	  latter	  interest.	  	  	  Chapter	  eight	  offers	  a	  critical	  assessment	  of	  how	  six	  prominent	  proposals	  relate	  to	   the	   International	  Bill	  of	  Rights.	  After	  providing	  an	  extensive	  analysis	  of	  how	  intellectual	  property	  affects	  rights	  and	  freedoms	  protected	  by	  human	  rights	  law,	  the	  three	  above	  mentioned	  alternatives	  are	  examined	  in	  addition	  to	  the	  wide	  use	  of	   compulsory	   licences,	   prize	   funds	   and	  promoting	   South-­‐South	   collaborations.	  During	  this	  assessment	  human	  rights	  are	  not	  understood	  in	  the	  purely	  juridical	  sense,	  a	  lay	  assessment	  is	  offered	  instead.	  The	  purpose	  being	  that	  with	  such	  type	  of	  understanding	  the	  origin	  of	  much	  confusion	  can	  be	  understood.	  The	  result	  of	  this	  assessment	   is	   that	   the	  heterogeneity	  and	  diversity	  of	  needs	  we	   find	   in	   the	  world	  requires	  a	  much	  more	  complex	  solution.	  Some	  affected	  parties	  will	  often	  interpret	  concessions	  catalogued	  as	  minor	  by	  one	  section	  of	  the	  world	  as	  being	  major.	  A	  single	  major	  amendment	  will	  be	  far	  from	  solving	  this	  complex	  problem	  in	  its	  totality.	  	  	  Throughout	  the	  thesis	  I	  have	  been	  keen	  to	  state	  the	  need	  of	  making	  science	  and	  technology	   development	   a	   more	   inclusive	   endeavour.	   Here	   I	   share	   the	   same	  spirit	   with	   many	   other	   political	   philosophers	   in	   persistently	   claiming	   that	  participation	  is	  crucial	  for	  a	  well-­‐functioning	  society.	  In	  the	  realm	  of	  science	  and	  technology	   development	   participation	   can	   only	   be	   meaningful	   if	   systematic	  discrimination	  is	  absent	  and	  sufficient	  possibilities	  to	  learn	  the	  needed	  skills	  are	  present.	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